Engineering the unicellular alga Phaeodactylum tricornutum for high‐value plant triterpenoid production. Issue 1 (19th June 2018)

• Record Type: Journal Article
• Authors: D'Adamo, Sarah; Schiano di Visconte, Gino; Lowe, Gavin; Szaub‐Newton, Joanna; Beacham, Tracey; Landels, Andrew; Allen, Michael J.; Spicer, Andrew; Matthijs, Michiel
• Is Part Of: Plant biotechnology journal. Volume 17:Issue 1(2019)
• Page Start: 75
• Page End: 87
• Publication Date: 2018-06-19
• Subjects: triterpenoid biosynthesis -- natural product -- algal synthetic biology -- diatoms -- microalgae -- lupeol -- betulin -- blue biotechnology; Plant biotechnology -- Periodicals; Plant genetic engineering -- Periodicals; 630.272
• DOI: 10.1111/pbi.12948
• Languages: English
• ISSNs: 1467-7644

Abstract

Summary: Plant triterpenoids constitute a diverse class of organic compounds that play a major role in development, plant defence and environmental interaction. Several triterpenes have demonstrated potential as pharmaceuticals. One example is betulin, which has shown promise as a pharmaceutical precursor for the treatment of certain cancers and HIV. Major challenges for triterpenoid commercialization include their low production levels and their cost‐effective purification from the complex mixtures present in their natural hosts. Therefore, attempts to produce these compounds in industrially relevant microbial systems such as bacteria and yeasts have attracted great interest. Here, we report the production of the triterpenes betulin and its precursor lupeol in the photosynthetic diatom Phaeodactylum tricornutum, a unicellular eukaryotic alga. This was achieved by introducing three plant enzymes in the microalga: a Lotus japonicus oxidosqualene cyclase and a Medicago truncatula cytochrome P450 along with its native reductase. The introduction of the L. japonicus oxidosqualene cyclase perturbed the mRNA expression levels of the native mevalonate and sterol biosynthesis pathway. The best performing strains were selected and grown in a 550‐L pilot‐scale photobioreactor facility. To our knowledge, this is the most extensive pathway engineering undertaken in a diatom and the first time that a sapogenin has been artificially produced in a microalga, demonstrating the feasibility of the photo‐bio‐production of more complex high‐value, metabolites in microalgae.